scholarly article | Q13442814 |
P356 | DOI | 10.1093/NAR/GKT213 |
P8608 | Fatcat ID | release_35arcklfvra3lck73wctnp2uru |
P932 | PMC publication ID | 3643609 |
P698 | PubMed publication ID | 23558747 |
P5875 | ResearchGate publication ID | 236114015 |
P50 | author | Manel Esteller | Q3816008 |
Michael J. Hendzel | Q42407069 | ||
P2093 | author name string | Juan Ausió | |
Brad Williamson | |||
Marlee K Ng | |||
Kristal Missiaen | |||
David McPhee | |||
Alexia Martinez de Paz | |||
David P Stuss | |||
Joel D Cosman | |||
Kerry Delaney | |||
Manjinder Cheema | |||
P2860 | cites work | Identification and characterization of a family of mammalian methyl-CpG binding proteins | Q22003967 |
Rett syndrome is caused by mutations in X-linked MECP2, encoding methyl-CpG-binding protein 2 | Q22337290 | ||
Expression of MeCP2 in postmitotic neurons rescues Rett syndrome in mice | Q24568049 | ||
Characterization of MeCP2, a vertebrate DNA binding protein with affinity for methylated DNA | Q24629535 | ||
Structure-specific binding of MeCP2 to four-way junction DNA through its methyl CpG-binding domain | Q24814601 | ||
Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 | ||
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method | Q25938999 | ||
Chromatin compaction by human MeCP2. Assembly of novel secondary chromatin structures in the absence of DNA methylation | Q28177120 | ||
Intrinsically disordered protein | Q28191444 | ||
Molecular genetics of Rett syndrome: when DNA methylation goes unrecognized | Q28240924 | ||
Purification, sequence, and cellular localization of a novel chromosomal protein that binds to methylated DNA | Q28265233 | ||
SPKK, a new nucleic acid-binding unit of protein found in histone | Q28339810 | ||
A mouse Mecp2-null mutation causes neurological symptoms that mimic Rett syndrome | Q28504458 | ||
Insight into Rett syndrome: MeCP2 levels display tissue- and cell-specific differences and correlate with neuronal maturation | Q28509347 | ||
Components of the DNA methylation system of chromatin control are RNA-binding proteins | Q28509434 | ||
The major form of MeCP2 has a novel N-terminus generated by alternative splicing | Q28511496 | ||
MECP2 is progressively expressed in post-migratory neurons and is involved in neuronal maturation rather than cell fate decisions | Q28511729 | ||
MeCP2 is a transcriptional repressor with abundant binding sites in genomic chromatin | Q28576622 | ||
Analysis of protein domains and Rett syndrome mutations indicate that multiple regions influence chromatin-binding dynamics of the chromatin-associated protein MECP2 in vivo | Q28591033 | ||
The expression of methyl CpG binding factor MeCP2 correlates with cellular differentiation in the developing rat brain and in cultured cells | Q28941207 | ||
Imaging neuronal subsets in transgenic mice expressing multiple spectral variants of GFP | Q29547505 | ||
Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis | Q29547538 | ||
Comparative study of brain morphology in Mecp2 mutant mouse models of Rett syndrome | Q46146028 | ||
A rodent model of protein turnover used to design an experiment for measuring the rates of channeling, recycling and protein synthesis | Q46320924 | ||
Comparison of turnover rates of proteins of the brain, liver and kidney in mouse in vivo following long term labeling | Q48393340 | ||
MeCP2 post-translational regulation through PEST domains: two novel hypotheses: potential relevance and implications for Rett syndrome | Q50341204 | ||
Presence of a highly specific histone H1-like protein in the chromatin of the sperm of the bivalve mollusks | Q67590874 | ||
Preferential binding of histone H1 to four-way helical junction DNA | Q70500424 | ||
Dynamics and equilibria of nucleosomes at elevated ionic strength | Q71300679 | ||
Importance of fixation in immunohistochemistry: use of formaldehyde solutions at variable pH for the localization of tyrosine hydroxylase | Q72641619 | ||
Effects of Rett syndrome mutations of the methyl-CpG binding domain of the transcriptional repressor MeCP2 on selectivity for association with methylated DNA | Q73893290 | ||
Characterization of the stability and folding of H2A.Z chromatin particles: implications for transcriptional activation | Q74499946 | ||
The methyl-CpG binding transcriptional repressor MeCP2 stably associates with nucleosomal DNA | Q77828158 | ||
MeCP2-chromatin interactions include the formation of chromatosome-like structures and are altered in mutations causing Rett syndrome | Q80693217 | ||
Beyond the Xi: macroH2A chromatin distribution and post-translational modification in an avian system | Q81414585 | ||
H2A.Z stabilizes chromatin in a way that is dependent on core histone acetylation | Q83364389 | ||
Deficiency of methyl-CpG binding protein-2 in CNS neurons results in a Rett-like phenotype in mice | Q29616328 | ||
PEST sequences and regulation by proteolysis | Q29616394 | ||
Characterization of the histone H2A.Z-1 and H2A.Z-2 isoforms in vertebrates | Q30437379 | ||
Phosphorylation of MeCP2 at Serine 80 regulates its chromatin association and neurological function. | Q30438464 | ||
Biophysical analysis and small-angle X-ray scattering-derived structures of MeCP2-nucleosome complexes | Q30500778 | ||
The affinity of different MBD proteins for a specific methylated locus depends on their intrinsic binding properties | Q33186320 | ||
Cerebellar gene expression profiles of mouse models for Rett syndrome reveal novel MeCP2 targets | Q33288477 | ||
Identification of novel reference genes using multiplatform expression data and their validation for quantitative gene expression analysis | Q33479558 | ||
Unique physical properties and interactions of the domains of methylated DNA binding protein 2. | Q33860692 | ||
MeCP2 binds cooperatively to its substrate and competes with histone H1 for chromatin binding sites | Q34178049 | ||
MeCP2 mutation results in compartment-specific reductions in dendritic branching and spine density in layer 5 motor cortical neurons of YFP-H mice | Q34193020 | ||
A previously unidentified MECP2 open reading frame defines a new protein isoform relevant to Rett syndrome | Q34307505 | ||
NPDC-1, a novel regulator of neuronal proliferation, is degraded by the ubiquitin/proteasome system through a PEST degradation motif | Q34330444 | ||
Real-time PCR for mRNA quantitation | Q34439106 | ||
Novel MeCP2 isoform-specific antibody reveals the endogenous MeCP2E1 expression in murine brain, primary neurons and astrocytes | Q34490485 | ||
Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA. | Q34634739 | ||
MeCP2 is required for global heterochromatic and nucleolar changes during activity-dependent neuronal maturation. | Q34988096 | ||
Binding of the Rett syndrome protein, MeCP2, to methylated and unmethylated DNA and chromatin. | Q34988885 | ||
Using FRAP and mathematical modeling to determine the in vivo kinetics of nuclear proteins. | Q35051219 | ||
Neuronal MeCP2 is expressed at near histone-octamer levels and globally alters the chromatin state. | Q35114553 | ||
Linking epigenetics to human disease and Rett syndrome: the emerging novel and challenging concepts in MeCP2 research | Q35838075 | ||
MeCP2 binds to nucleosome free (linker DNA) regions and to H3K9/H3K27 methylated nucleosomes in the brain | Q35888788 | ||
Phosphorylation of distinct sites in MeCP2 modifies cofactor associations and the dynamics of transcriptional regulation | Q36155083 | ||
DNA methylation specifies chromosomal localization of MeCP2. | Q36556949 | ||
The role of MeCP2 in the brain. | Q37896649 | ||
Intrinsic disorder and autonomous domain function in the multifunctional nuclear protein, MeCP2. | Q38303577 | ||
Nucleosomes protect DNA from DNA methylation in vivo and in vitro. | Q38319446 | ||
Genome-wide activity-dependent MeCP2 phosphorylation regulates nervous system development and function | Q39461991 | ||
Expression profiles of mRNA transcript variants encoding the human inhibitor of growth tumor suppressor gene family in normal and neoplastic tissues | Q40089440 | ||
Cooperative interaction of histone H1 with DNA. | Q40561509 | ||
The latency-associated nuclear antigen interacts with MeCP2 and nucleosomes through separate domains | Q41860564 | ||
Nucleosome linker DNA contacts and induces specific folding of the intrinsically disordered H1 carboxyl-terminal domain | Q42111436 | ||
Coil-to-helix transitions in intrinsically disordered methyl CpG binding protein 2 and its isolated domains | Q42202391 | ||
Multiple modes of interaction between the methylated DNA binding protein MeCP2 and chromatin. | Q42952032 | ||
MeCP2 preferentially binds to methylated linker DNA in the absence of the terminal tail of histone H3 and independently of histone acetylation | Q43863138 | ||
Disease modeling using embryonic stem cells: MeCP2 regulates nuclear size and RNA synthesis in neurons | Q43880632 | ||
Widespread changes in dendritic and axonal morphology in Mecp2-mutant mouse models of Rett syndrome: evidence for disruption of neuronal networks | Q46083730 | ||
P275 | copyright license | Creative Commons Attribution-NonCommercial 3.0 Unported | Q18810331 |
P6216 | copyright status | copyrighted | Q50423863 |
P4510 | describes a project that uses | ImageJ | Q1659584 |
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 4888-4900 | |
P577 | publication date | 2013-04-04 | |
P1433 | published in | Nucleic Acids Research | Q135122 |
P1476 | title | Impaired in vivo binding of MeCP2 to chromatin in the absence of its DNA methyl-binding domain | |
P478 | volume | 41 |
Q36094434 | A high-resolution imaging approach to investigate chromatin architecture in complex tissues |
Q41528599 | Ethanol deregulates Mecp2/MeCP2 in differentiating neural stem cells via interplay between 5-methylcytosine and 5-hydroxymethylcytosine at the Mecp2 regulatory elements |
Q58580302 | Genomic mosaicism in the pathogenesis and inheritance of a Rett syndrome cohort |
Q35489376 | Genotype-specific effects of Mecp2 loss-of-function on morphology of Layer V pyramidal neurons in heterozygous female Rett syndrome model mice |
Q38853829 | MECP2, a multi-talented modulator of chromatin architecture |
Q50302685 | MeCP2 Binding Cooperativity Inhibits DNA Modification-Specific Recognition. |
Q26747013 | MeCP2 and the enigmatic organization of brain chromatin. Implications for depression and cocaine addiction |
Q50993055 | MeCP2, A Modulator of Neuronal Chromatin Organization Involved in Rett Syndrome. |
Q37632847 | MeCP2-Related Diseases and Animal Models |
Q38451083 | Methyl-CpG-binding domain proteins: readers of the epigenome |
Q40036997 | Rett Syndrome Mutant Neural Cells Lacks MeCP2 Immunoreactive Bands. |
Q38194967 | Rett syndrome and MeCP2. |
Q47718746 | Stem Cell Technology for (Epi)genetic Brain Disorders. |
Q47445768 | Trichostatin A decreases the levels of MeCP2 expression and phosphorylation and increases its chromatin binding affinity |
Q38307079 | Unusual characteristics of the DNA binding domain of epigenetic regulatory protein MeCP2 determine its binding specificity |
Search more.